World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 15 April 2024
Main ID:  ISRCTN55546280
Date of registration: 16/02/2017
Prospective Registration: No
Primary sponsor: Humanitas Mater Domini - Castellanza
Public title: The role of surgical treatment on lower pole renal stones
Scientific title: A prospective randomized comparison among shock wave lithotripsy, percutaneous lithotripsy and retrograde intrarenal surgery for lower calyceal stones less than 2 cm: a multicenter experience
Date of first enrolment: 01/01/2010
Target sample size: 176
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN55546280
Study type:  Interventional
Study design:  Multicenter randomized unblinded clinical trial (Treatment)  
Phase:  Not Applicable
Countries of recruitment
Austria England Italy Russian Federation United Kingdom
Contacts
Name: Giorgio    Bozzini
Address:  via Gerenzano 2 21053 Castellanza Italy
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Consecutive patients with a single LP stone with a diameter of 1 to 2 cm as measured at CT scan, that received the indication of active removal according to EAU Guidelines
2. Age between 18 and 75 years

Exclusion criteria: 1. Presence of coagulation disorders
2. Age under 18 or over 75 years
3. Presence of acute infection (fever more than 38° C or total leucocyte count more than 15000/dl)
4. Presence of solitary kidney
5. Coexisting ureteric disease (tumour or stricture)
6. Pregnancy
7. Presence of cardiovascular or pulmonary comorbidities
8. Multiple stones
9. Steep infundibolar-pelvic angle (< 30°)
10. Longer calyx more than 10 mm
11. Narrow infundibulum (less than 5 mm) as demonstrated by contrast enhanced CT
12. Patients who refuse to give consent to the study


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Renal lower calyceal stones
Urological and Genital Diseases
Intervention(s)
Patients will be randomized into three groups:
Group A: SWL
Group B: RIRS
Group C: PCNL

The randomization allocation sequence will be produced with the online free Random Allocation Software (M. Saghaei, MD). The principal investigator for each center will enroll and assign participants to groups. The randomization will be stratified by center. Each center will use their own equipment to perform treatments, but the procedures will be standardized and were supervised by an experienced surgeon in the field of stone management.

SWL will be performed with ultrasound or x-ray guided targeting of the stone with a frequency of 100 impulses/min and a maximum of 2500 shock waves (SW) per session. Patients will be observed for at least two hours after the SWL and then discharged as an outpatient procedure.

RIRS will be performed with a flexible ureteroscope and a 30 W Holmium YAG Laser device. Before the sheath insertion, an ureteric dilatation will be performed when required. Bigger fragments will be removed with a stone retrieval basket. After the procedure a double J stent will be inserted in all patients and its removal will be planned after 4 weeks if the patient will be stone free.

PCNL will be performed with a rigid nephroscope 20.8 to 24 Fr. and a 30 W Holmium YAG Laser device. PCNL will be performed with the patient either in prone or modified supine position according to the operator’s preference. The kidney puncture will be performed under fluoroscopic and/or US guidance. Calyx will be cleaned removing bigger fragments with a stone retrieval basket. Each patient will have a nephrostomy tube placement after the procedure removed after two days if urine is clear.

A stone analysis will be performed in all cases, when fragments available. Patients affected by uric ac
Primary Outcome(s)
Stone-free rate (SFR), defined as a negative CT scan or an asymptomatic patient with stone fragments less than 3 mm and a negative urine culture, measured at 3 months
Secondary Outcome(s)
Peri- and post-operative complications of procedures, classified using the validated Dindo-modified Clavien System, during the hospitalization and until 3 months
Secondary ID(s)
2009-001328-14
77/gb/2009
Source(s) of Monetary Support
European Association of Urology
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Old ethics approval format; ASL Milano 2, 12/03/2009, ref: 2009/2388/DU
Results
Results available: Yes
Date Posted:
Date Completed: 31/12/2014
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history